<p>Stratified analysis for species distribution, carbapenem susceptibilities, and distribution of carbapenemases by hospital types.</p
<p>Distribution, initiation of treatment and in-hospital mortality of patients colonized or infected...
<p>Analyzed species/varieties and their vouchers, locations, and ploidy levels.</p
<p>Each circle represents a sequence type (ST), which number is given besides the circle. The size o...
<p>Distribution of the <i>Candida</i> species according to underlying pathology/medical care (n).</p
<p>Overview of Carbapenemase-producing Genotypes in the Health and Surveillance Systems of the U.S. ...
<p>Scatterplot of prevalence of carbapenem-resistant <i>Pseudomonas</i> sp. per 100 admissions and c...
<p>Distribution of different carbapenem-resistant <i>P</i>. <i>aeruginosa</i> pulsotypes in clinical...
<p>Candida spp. distribution expressed as percentage of total candida species in various hospital wa...
<p>Antimicrobial resistance profiles of CPE isolates according to species and carbapenemase variant....
Distribution of the prevalence of major pathogens causing CA-UTI among patients by age and sex.</p
<p><sup>a</sup>carbapenem-non-susceptible isolates (NS)</p><p><sup>b</sup>carbapenem susceptible iso...
<p>Distribution of <i>Campylobacter</i> species according to extent and severity of disease.</p
<p>Distribution of MICs according to the phylum of clinical isolates and reference strains.</p
<p>Total<sup>a</sup>: Total number of isolates with each resistance gene</p><p>%<sup>b</sup>: The pr...
<p>The distribution of <i>Candida</i> species among four major cancer categories.</p
<p>Distribution, initiation of treatment and in-hospital mortality of patients colonized or infected...
<p>Analyzed species/varieties and their vouchers, locations, and ploidy levels.</p
<p>Each circle represents a sequence type (ST), which number is given besides the circle. The size o...
<p>Distribution of the <i>Candida</i> species according to underlying pathology/medical care (n).</p
<p>Overview of Carbapenemase-producing Genotypes in the Health and Surveillance Systems of the U.S. ...
<p>Scatterplot of prevalence of carbapenem-resistant <i>Pseudomonas</i> sp. per 100 admissions and c...
<p>Distribution of different carbapenem-resistant <i>P</i>. <i>aeruginosa</i> pulsotypes in clinical...
<p>Candida spp. distribution expressed as percentage of total candida species in various hospital wa...
<p>Antimicrobial resistance profiles of CPE isolates according to species and carbapenemase variant....
Distribution of the prevalence of major pathogens causing CA-UTI among patients by age and sex.</p
<p><sup>a</sup>carbapenem-non-susceptible isolates (NS)</p><p><sup>b</sup>carbapenem susceptible iso...
<p>Distribution of <i>Campylobacter</i> species according to extent and severity of disease.</p
<p>Distribution of MICs according to the phylum of clinical isolates and reference strains.</p
<p>Total<sup>a</sup>: Total number of isolates with each resistance gene</p><p>%<sup>b</sup>: The pr...
<p>The distribution of <i>Candida</i> species among four major cancer categories.</p
<p>Distribution, initiation of treatment and in-hospital mortality of patients colonized or infected...
<p>Analyzed species/varieties and their vouchers, locations, and ploidy levels.</p
<p>Each circle represents a sequence type (ST), which number is given besides the circle. The size o...
View in ORKG
DOI